Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss PCI in de novo 3 vessel disease (SYNTAX II); DES vs. BMS in de novo saphenous vein graft lesions (DIVA); and sirolimus-eluting stents for preventing target lesion failure (BIOFLOW V).

Keywords: ESC2017, ESC Congress

< Back to Listings